Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jared Silver

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|February 26, 2025
Long-Term Safety and Efficacy of Mepolizumab in Eosinophilic Granulomatosis With PolyangiitisMichael E Wechsler, Jared Silver, Gerhard Wolff, et al.
The Journal of Experimental Medicine|December 17, 2017
Stochasticity enables BCR-independent germinal center initiation and antibody affinity maturationJared Silver, Teng Zuo, Neha Chaudhary, et al.
Journal of Asthma and Allergy|October 10, 2022
Profiling Disease and Economic Burden in CRSwNP Using Machine LearningNeil Bhattacharyya, Jared Silver, Michael Bogart, et al.
The Journal of Allergy and Clinical Immunology. Global|March 24, 2025
Eosinophilic granulomatosis with polyangiitis: Patient profiles from a large US allergy practiceMichael E Wechsler, Anna Kovalszki, Jared Silver, et al.
The Journal of Allergy and Clinical Immunology. Global|October 9, 2024
Peak nasal inspiratory flow assessment of polyp size and response from SYNAPSEAmber U Luong, Joshua M Levy, Ludger Klimek, et al.
OTO Open|October 17, 2022
Elucidating the Real-World Burden of Chronic Rhinosinusitis With Nasal Polyps in Patients in the USAVictoria S Benson, Guillaume Germain, Robert H Chan, et al.
The Journal of Allergy and Clinical Immunology. Global|September 22, 2025
Mepolizumab for the management of chronic rhinosinusitis with nasal polyps across the United States: A retrospective studyJuan Carlos Cardet, Jared Silver, Martin Maldonado-Puebla, et al.
The Journal of Allergy and Clinical Immunology. Global|May 7, 2026
Real-world outcomes and corticosteroid sparing with mepolizumab for EGPA or HESMichael E Wechsler, Anna Kovalszki, Brian Stone, et al.
International Forum of Allergy & Rhinology|June 22, 2023
Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24-week treatment-free follow-upMartin Desrosiers, Zuzana Diamant, Paolo Castelnuovo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 19, 2023
The Unified Airway Hypothesis: Evidence From Specific Intervention With Anti-IL-5 Biologic TherapyClaus Bachert, Amber U Luong, Philippe Gevaert, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Arthritis & Rheumatology (Hoboken, N.J.)|February 26, 2025
Long-Term Safety and Efficacy of Mepolizumab in Eosinophilic Granulomatosis With PolyangiitisMichael E Wechsler, Jared Silver, Gerhard Wolff, et al.
The Journal of Experimental Medicine|December 17, 2017
Stochasticity enables BCR-independent germinal center initiation and antibody affinity maturationJared Silver, Teng Zuo, Neha Chaudhary, et al.
Journal of Asthma and Allergy|October 10, 2022
Profiling Disease and Economic Burden in CRSwNP Using Machine LearningNeil Bhattacharyya, Jared Silver, Michael Bogart, et al.
The Journal of Allergy and Clinical Immunology. Global|March 24, 2025
Eosinophilic granulomatosis with polyangiitis: Patient profiles from a large US allergy practiceMichael E Wechsler, Anna Kovalszki, Jared Silver, et al.
The Journal of Allergy and Clinical Immunology. Global|October 9, 2024
Peak nasal inspiratory flow assessment of polyp size and response from SYNAPSEAmber U Luong, Joshua M Levy, Ludger Klimek, et al.
OTO Open|October 17, 2022
Elucidating the Real-World Burden of Chronic Rhinosinusitis With Nasal Polyps in Patients in the USAVictoria S Benson, Guillaume Germain, Robert H Chan, et al.
The Journal of Allergy and Clinical Immunology. Global|September 22, 2025
Mepolizumab for the management of chronic rhinosinusitis with nasal polyps across the United States: A retrospective studyJuan Carlos Cardet, Jared Silver, Martin Maldonado-Puebla, et al.
The Journal of Allergy and Clinical Immunology. Global|May 7, 2026
Real-world outcomes and corticosteroid sparing with mepolizumab for EGPA or HESMichael E Wechsler, Anna Kovalszki, Brian Stone, et al.
International Forum of Allergy & Rhinology|June 22, 2023
Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24-week treatment-free follow-upMartin Desrosiers, Zuzana Diamant, Paolo Castelnuovo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 19, 2023
The Unified Airway Hypothesis: Evidence From Specific Intervention With Anti-IL-5 Biologic TherapyClaus Bachert, Amber U Luong, Philippe Gevaert, et al.
Pageof 4